<SEC-DOCUMENT>0001437749-22-012004.txt : 20220512
<SEC-HEADER>0001437749-22-012004.hdr.sgml : 20220512
<ACCEPTANCE-DATETIME>20220512083520
ACCESSION NUMBER:		0001437749-22-012004
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20220512
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220512
DATE AS OF CHANGE:		20220512

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Moleculin Biotech, Inc.
		CENTRAL INDEX KEY:			0001659617
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				474671999
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37758
		FILM NUMBER:		22915855

	BUSINESS ADDRESS:	
		STREET 1:		5300 MEMORIAL DRIVE
		STREET 2:		SUITE 950
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77007
		BUSINESS PHONE:		713-300-5160

	MAIL ADDRESS:	
		STREET 1:		5300 MEMORIAL DRIVE
		STREET 2:		SUITE 950
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77007
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mbrx20220510_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:mbrx="http://www.mbrx.com/20220512"><head>
	<title>mbrx20220510_8k.htm</title>
	<!-- Generated by ThunderDome Portal - 5/11/2022 7:49:35 PM -->
<meta http-equiv="Content-Type" content="text/html" /></head>
<body style="cursor: auto; padding: 0in 0.1in; font-size: 10pt;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20228K" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20228K" name="dei:EntityCentralIndexKey">0001659617</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="mbrx-20220512.xsd" xlink:type="simple" />
</ix:references>
<ix:resources>
<xbrli:context id="d20228K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001659617</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2022-05-12</xbrli:startDate>
<xbrli:endDate>2022-05-12</xbrli:endDate>
</xbrli:period>
</xbrli:context>


</ix:resources>
</ix:header>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>UNITED STATES</b></div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>WASHINGTON, D.C. 20549</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>FORM <ix:nonNumeric contextRef="d20228K" name="dei:DocumentType"><b>8-K</b></ix:nonNumeric></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>CURRENT REPORT</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): <ix:nonNumeric contextRef="d20228K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate"><b>May 12, 2022</b></ix:nonNumeric></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="text-align: center; margin: 0pt;"><img alt="pic2.jpg" src="pic2.jpg" /></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20228K" name="dei:EntityRegistrantName"><b>MOLECULIN BIOTECH, INC.</b></ix:nonNumeric></div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">(Exact Name of Registrant as Specified in its Charter)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><span style="text-transform:uppercase;">Delaware</span></ix:nonNumeric></div>
			</td>
			<td style="vertical-align: middle; width: 34%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20228K" name="dei:EntityFileNumber"><b>001-37758</b></ix:nonNumeric></div>
			</td>
			<td style="vertical-align: middle; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20228K" name="dei:EntityTaxIdentificationNumber"><b>47-4671997</b></ix:nonNumeric></div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">(State or Other Jurisdiction of Incorporation</div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">or Organization)</div>
			</td>
			<td style="vertical-align: top; width: 34%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">(Commission File No.)</div>
			</td>
			<td style="vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">(I.R.S. Employer Identification No.)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><ix:nonNumeric contextRef="d20228K" name="dei:EntityAddressAddressLine1"><b>5300 Memorial Drive</b></ix:nonNumeric>, <ix:nonNumeric contextRef="d20228K" name="dei:EntityAddressAddressLine2"><b>Suite 950</b></ix:nonNumeric>, <ix:nonNumeric contextRef="d20228K" name="dei:EntityAddressCityOrTown"><b>Houston</b></ix:nonNumeric>, <ix:nonNumeric contextRef="d20228K" name="dei:EntityAddressStateOrProvince"><b><b>TX</b></b></ix:nonNumeric> <ix:nonNumeric contextRef="d20228K" name="dei:EntityAddressPostalZipCode"><b>77007</b></ix:nonNumeric></b></div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">(Address of principal executive offices and zip code)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(<ix:nonNumeric contextRef="d20228K" name="dei:CityAreaCode"><b>713</b></ix:nonNumeric>) <ix:nonNumeric contextRef="d20228K" name="dei:LocalPhoneNumber"><b>300-5160</b></ix:nonNumeric></b></div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">(Registrant&#8217;s telephone number, including area code)</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">(Former name or former address, if changed from last report)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 24pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i>see </i>General Instruction A.2. below):</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14(c))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).&#xa0; Emerging growth company&#xa0;<ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#xa0;&#9744;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Title of each class</b></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 34%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Trading Symbol (s)</b></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Name of each exchange on which registered</b></div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20228K" name="dei:Security12bTitle">Common Stock</ix:nonNumeric>, par value $.001 per share</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 34%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20228K" name="dei:TradingSymbol">MBRX</ix:nonNumeric></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">The <ix:nonNumeric contextRef="d20228K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric> Stock Market LLC</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#xa0;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 2.02</b>&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;<b>Results of Operations and Financial Condition.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On May 12, 2022, Moleculin Biotech, Inc. (the &#8220;Company&#8221;) issued a press release announcing its financial results for the three months ended March 31, 2022 and recent operational highlights. A copy of the press release is attached to this report as Exhibit 99.1 and is incorporated by reference herein.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 9.01 </b>&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;<b>Financial Statements and Exhibits.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 16pt;text-indent:21pt;">(d)&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;Exhibits.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Exhibit No. </b></div>
			</td>
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Description</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 5%;">
			<div style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">99.1</div>
			</td>
			<td style="width: 95%;">
			<div style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="ex_373512.htm" style="-sec-extract:exhibit;">Press Release dated May 12, 2022</a></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 5%;">
			<div style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">104</div>
			</td>
			<td style="width: 95%;">
			<div style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Cover page Interactive Data File (embedded within the Inline XBRL document)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><span style="text-decoration: underline;">SIGNATURE</span></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;text-indent:36pt;">Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:4.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:4.9%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>MOLECULIN BIOTECH, INC.</b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:4.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:4.9%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:4.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:4.9%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:4.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:4.9%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date: May 12, 2022</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:4.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:4.9%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:4.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:4.9%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By: <span style="text-decoration: underline;">/s/ Jonathan P. Foster</span></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:4.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:4.9%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Jonathan P. Foster</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Chief Financial Officer</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center;">2</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex_373512.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_373512.htm</title>
	<!-- Generated by ThunderDome Portal - 5/11/2022 7:51:10 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="cursor: auto; padding: 0in 0.1in; font-size: 10pt;">
<p style="margin-bottom: 0px; text-align: right; margin-top: 0px"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 99.1</b></font></p>

<div>
<div><img alt="moleculinnewlogoresized.jpg" src="moleculinnewlogoresized.jpg"></div>
</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>Moleculin Reports First Quarter 2022 Financial Results and Provides Programs Update</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 24pt;"><i>&#8211; Positive advancements, encouraging preclinical and clinical data, and development activity in all three core technologies </i>&#8211;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 24pt;"><i>&#8211; Multiple key clinical and regulatory milestones expected throughout 2022 </i>&#8211;<i> </i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><i>&#8211; Company has sufficient capital to fund operations into 2024 </i>&#8211;<i> </i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>HOUSTON, May 12, 2022 /PRNewswire/ -- Moleculin Biotech, Inc.</b>, (Nasdaq: MBRX) (&#8220;Moleculin&#8221; or the &#8220;Company&#8221;), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today reported its financial results for the quarter ended March 31, 2022. The Company also provided an update on its portfolio of oncology drug candidates for the treatment of highly resistant tumors and viruses.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#8220;We have continued to make excellent progress across our entire pipeline since the start of 2022, paving the way for important data readouts throughout this year,&#8221; commented Walter Klemp, Chairman and CEO of Moleculin. &#8220;Importantly, our clinical and regulatory strategies have expanded significantly outside of the U.S. and we recently bolstered the expertise of our leadership team to drive our EU clinical trials forward. Our development programs for Annamycin in STS lung mets and AML, as well as WP1122 for COVID-19 and GBM continue to advance. With the progress we&#8217;ve made and the milestones ahead, 2022 is poised to be an important year for not only providing more clarity for each clinical program&#8217;s path towards registration, but also an opportunity to unlock value for all stakeholders, and importantly, addressing unmet needs for people with highly resistant tumors and viruses.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>Recent Highlights </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 27pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Received required authorizations for an amendment to commencement a Phase 1a clinical trial of WP1122 in the United Kingdom (UK) for the treatment of COVID-19.</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 27pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: 18pt; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#9679;</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Received allowance from the Polish Department of Registration of Medicinal Products (URPL), as well as the requisite Ethics Committee approval, to proceed with its Phase 1/2 clinical trial in Poland of Annamycin (L-ANN) in combination with Cytarabine (Ara-C) in the treatment of subjects with acute myeloid leukemia (AML) who are refractory to or relapsed after induction therapy.</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 27pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Engaged Wolfram C. M. Dempke, MD, PhD, MBA as its European Chief Medical Officer and part-time contractor for its European clinical trials.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 27pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Received IND clearance to conduct Phase 1 study of WP1066 for the treatment of recurrent malignant glioma.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 27pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Presented preclinical data at the AACR 2022 Annual Meeting demonstrating Annamycin exhibited robust antitumor activity in experimental colorectal cancer liver and lung metastasis models.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 27pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#9679;</p>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Launched new corporate branding and website.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Programs Update </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Next Generation Anthracycline </b>&#8211;<b> Annamycin</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Annamycin is the Company's next-generation anthracycline that has been shown in animal models to accumulate in the lungs at up to 30-fold the level of doxorubicin, as well as demonstrating the ability to avoid the multidrug resistance mechanisms that typically limit the efficacy of doxorubicin and other currently prescribed anthracyclines. Importantly, Annamycin has also demonstrated a lack of cardiotoxicity in multiple human clinical trials, including ongoing trials for the treatment of relapsed or refractory acute myeloid leukemia (AML) and soft tissue sarcoma (STS) lung metastases, and the Company believes that the use of Annamycin may not face the same usage limitations imposed on doxorubicin, one of the most common currently prescribed anthracyclines. Annamycin is currently in development for the treatment of AML and STS lung metastases and the Company believes it may have the potential to treat a number of additional indications.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Annamycin currently has Fast Track Status and Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for the treatment of STS lung metastases, in addition to Orphan Drug Designation for the treatment of relapsed or refractory acute myeloid leukemia.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For more information about the Phase 1b/2 study evaluating Annamycin for the treatment of STS lung metastases, please visit clinicaltrials.gov and reference identifier NCT04887298.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Upcoming Milestones Expectations</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">Q2 2022: Commence Phase 1/2 study in Europe for the treatment of AML evaluating combination therapy of Annamycin + Ara-C.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">Q2 2022: Commencement of an investigator-funded, second Phase 1b/2 clinical trial of Annamycin in sarcoma lung metastases in Europe.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">Q2 2022: Report topline data from Phase 1b portion of ongoing Phase 1b/2 study of Annamycin for the treatment of sarcoma lung metastases in the US.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Metabolism/Glycosylation Inhibitor </b>&#8211;<b> WP1122</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">WP1122, the Company&#8217;s lead metabolism/glycosylation inhibitor, is a prodrug of a well-known glucose decoy called 2-deoxy-D-glucose (2-DG), currently being developed by an unrelated third party in India for inhibition of viral replication and disease manifestations in humans infected with SARS-CoV-2, the virus responsible for COVID-19. The Company is also evaluating WP1122 for the treatment of Glioblastoma Multiforme (GBM). The mechanism of action of 2-DG includes both the inhibition of glycolysis and the disruption of glycosylation, two processes that are important to both viral activity and tumor development. WP1122 was developed as a 2-DG prodrug to provide a more favorable pharmacological profile, and was found to have greater potency than 2-DG alone in preclinical models where tumor cells require higher glycolytic activity than normal cells. WP1122 has also been shown to have a more potent antiviral effect than 2-DG against SARS-CoV-2 in MRC-5 cells (one of the most common human-derived cell lines used for antiviral research) in culture.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>COVID-19 </i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company has received authorization from the Medicines and Healthcare Products Regulatory Agency (MHRA) to commence a Phase 1a clinical trial of WP1122 in the United Kingdom (UK). The Company also received a favorable opinion from the London &#8211; Riverside Research Ethics Committee in the UK to begin the study, which is expected to be conducted at the Medicines Evaluation Unit in Manchester, United Kingdom. In May 2022, the Company received approval from both the Riverside Ethics Committee and the MHRA for its amended study protocol to update the dilution of the oral solution to achieve full dissolution of WP1122. No risk/benefit to the study was affected because of this change. The Phase 1a study in healthy human volunteers will investigate the effects of a single ascending dose (SAD) and multiple days of ascending dosing (MAD) of WP1122 administered as an oral solution. Dose escalation will take place in sequential SAD cohorts, and MAD will start as soon as SAD has completed at least 3 dosing cohorts in which WP1122 is found to be safe and well-tolerated. This study in healthy volunteers will explore safety and pharmacokinetics (PK), and subsequent clinical development will be in patients infected with SARS-CoV-2 to further evaluate safety and establish a favorable risk/benefit profile. The Company expects to enroll approximately 80 healthy volunteers in the United Kingdom.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Glioblastoma Multiforme</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Additionally, Moleculin recently received IND clearance from the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 open label, single arm, dose escalation study of the safety, pharmacokinetics and efficacy of oral WP1122 in adult patients with GBM, which the Company expects to commence in 2022.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Upcoming Milestones Expectations</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">Q2 2022: Commence recruitment in Phase 1a study of WP1122 for the treatment of COVID-19 in the UK.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">H2 2022: Potential to launch Phase 2 study of WP1122 for the treatment of COVID-19 outside of the US.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">2022: Identify investigators interested in initiating a Phase 1 open label, single arm, dose escalation study of the safety, pharmacokinetics and efficacy of oral WP1122 in adult patients with GBM.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">Ongoing preclinical development work in additional anti-viral indications such as HIV, Zika, and Dengue. Collaborations targeted for 2022.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Summary of Financial Results for the First Quarter 2022</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Research and development (R&amp;D) expense was $4.6 million and $4.1 million for the three months ended March 31, 2022 and 2021, respectively. The increase of $0.5 million is mainly related to increased clinical trial activity as described above, a license termination fee, and costs related to manufacturing of additional drug product.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">General and administrative expense was $2.4 million and $1.9 million for the three months ended March 31, 2022 and 2021, respectively. The increase of&nbsp;$0.5&nbsp;million is mainly related to an increase&nbsp;in regulatory legal services, consulting and advisory fees.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For the three months ended March 31, 2022 and 2021, the Company reported a net loss of $6.9 million and $4.4 million, respectively, and had net cash flows used in operating activities of $4.8 million and $3.6 million, respectively.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company ended the quarter with $66.1 million of cash. The Company believes that this cash is sufficient to meet its projected operating requirements, which include a forecasted increase over its current R&amp;D rate of expenditures, into 2024.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>About Moleculin Biotech, Inc.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Moleculin Biotech, Inc. is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of highly resistant tumors and viruses. The Company&#8217;s lead program, Annamycin is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity. Annamycin is currently in development for the treatment of relapsed or refractory acute myeloid leukemia (AML) and soft tissue sarcoma (STS) lung metastases.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Additionally, the Company is developing WP1066, an Immune/Transcription Modulator capable of inhibiting p-STAT3 and other oncogenic transcription factors while also stimulating a natural immune response, targeting brain tumors, pancreatic and other cancers, and WP1220, an analog to WP1066, for the topical treatment of cutaneous T-cell lymphoma. Moleculin is also engaged in the development of a portfolio of antimetabolites, including WP1122 for the potential treatment of COVID-19 and other viruses, as well as cancer indications including brain tumors, pancreatic and other cancers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For more information about the Company, please visit www.moleculin.com and connect on Twitter, LinkedIn and Facebook.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Forward-Looking Statements</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, the Company's ability to meet the milestones described in this release under the sections &#8220;Upcoming Milestones Expectations&#8221;, the Company's forecasted cash burn rate, and due to the volatility and unpredictability of COVID-19 incidence in various countries, the Company&#8217;s ability to recruit subjects to conduct such a study. Although Moleculin believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Moleculin has attempted to identify forward-looking statements by terminology including ''believes,'' ''estimates,'' ''anticipates,'' ''expects,'' ''plans,'' ''projects,'' ''intends,'' ''potential,'' ''may,'' ''could,'' ''might,'' ''will,'' ''should,'' ''approximately'' or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including those discussed under Item 1A. "Risk Factors" in our most recently filed Form 10-K filed with the Securities and Exchange Commission ("SEC") and updated from time to time in our Form 10-Q filings and in our other public filings with the SEC. Any forward-looking statements contained in this release speak only as of its date. We undertake no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Investor Contact:</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">JTC Team, LLC</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Jenene Thomas</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(833) 475-8247</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">MBRX@jtcir.com</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>-- Financial Tables Follow</b>&#8212;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; margin-left: 0pt; margin-right: 0pt;">

		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><b>Moleculin Biotech, Inc.</b></p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><b>Unaudited Condensed Consolidated Balance Sheets </b></p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><b>(in thousands)</b></p>
			</td>
			<td id=".lead.D2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><b>March 31, 2022</b></b></p>
			</td>
			<td id=".trail.D2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><b>December 31, 2021</b></b></p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Current assets:</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Cash and cash equivalents</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">66,104</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">70,903</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Prepaid expenses and other current assets</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">1,156</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">1,594</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Total current assets</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">67,260</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">72,497</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Furniture and equipment, net</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">312</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">338</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Intangible assets</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">11,148</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">11,148</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Operating lease right-of-use asset</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">81</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">107</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Total assets</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">78,801</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">84,090</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Current liabilities:</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Accounts payable and accrued expenses and other current liabilities</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">4,834</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">3,622</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Total current liabilities</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">4,834</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">3,622</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Operating lease liability - long-term, net of current portion</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">50</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">63</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Warrant liability - long term</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,252</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,412</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Total liabilities</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">6,136</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">5,097</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Total stockholders' equity</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">72,665</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">78,993</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Total liabilities and stockholders' equity</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">78,801</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">84,090</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; margin-left: 0pt; margin-right: 0pt;">

		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><b>Unaudited Condensed Consolidated Statements of Operations</b></p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="6" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><b>Three Months Ended March 31,</b></b></p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><b>(in thousands, except share and per share amounts)</b></p>
			</td>
			<td id=".lead.D2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><b>2022</b></b></p>
			</td>
			<td id=".trail.D2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><b>2021</b></b></p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Revenues</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Operating expenses:</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Research and development</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">4,620</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">4,105</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">General and administrative and depreciation</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,454</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,983</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Total operating expenses</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">7,074</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">6,088</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Loss from operations</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(7,074</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(6,088</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Other income:</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Gain from change in fair value of warrant liability</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">160</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1,577</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Other income, net</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">5</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">9</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Interest income, net</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">42</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">57</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Net loss</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(6,867</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(4,445</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Net loss per common share - basic and diluted</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">(0.24</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">(0.20</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Weighted average common shares outstanding - basic and diluted</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">28,578,338</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">21,808,565</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>mbrx-20220512.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 5/11/2022 7:49:36 PM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:mbrx="http://www.mbrx.com/20220512" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.mbrx.com/20220512">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mbrx-20220512_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mbrx-20220512_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mbrx-20220512_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.mbrx.com/20220512/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="mbrx_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>mbrx-20220512_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 5/11/2022 7:49:36 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.mbrx.com/20220512/role/statement-document-and-entity-information" xlink:href="mbrx-20220512.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.mbrx.com/20220512/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="23" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>mbrx-20220512_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 5/11/2022 7:49:36 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine2-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line Two</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>mbrx-20220512_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 5/11/2022 7:49:36 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.mbrx.com/20220512/role/statement-document-and-entity-information" xlink:href="mbrx-20220512.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.mbrx.com/20220512/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>moleculinnewlogoresized.jpg
<TEXT>
begin 644 moleculinnewlogoresized.jpg
M_]C_X  02D9)1@ ! 0  E@"6  #_X0",17AI9@  34T *@    @ !0$2  ,
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MUO;T%Q%P%DN!PV)E@LWA4KT':=.4>1M]5!MOF:UT5^U[V/UD37]#DN?L<=Y
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MM#+:^?*K#$X-12]FDXU%&UKWVU2;VW:N?&__  2A\!ZRZ_$'XFRQ,FG+I?\
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MJY'\(K]OOBU^PE\"/C5\3&^+'C:._;5V6W&8+IHH\6QRGR#CZ^M>[_%SX,>
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K "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>pic2.jpg
<TEXT>
begin 644 pic2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !8 1@# 2(  A$! Q$!_\0
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MK4:M&K*C6CRRCH2#@4444B HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?\EQNO\ L//_ .CZ_8+QN?\ BWVI?]>$G_HLU^//B BU^.-YYGR>7KK[]_\
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M;_[]>Q?LCZI\<;C]H[PTGB?_ (3G^PO.F^V_;HIO(QY$GW]_^WLK] BBIT4
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(4 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140131987213528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>May 12, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">MOLECULIN BIOTECH, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">May 12,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">001-37758<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">47-4671997<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">5300 Memorial Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity, Address, Address Line Two</a></td>
<td class="text">Suite 950<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Houston<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">77007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">713<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">300-5160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MBRX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0001659617<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>mbrx20220510_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mbrx-20220512.xsd" xlink:type="simple"/>
    <context id="d20228K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001659617</identifier>
        </entity>
        <period>
            <startDate>2022-05-12</startDate>
            <endDate>2022-05-12</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20228K">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20228K">0001659617</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20228K">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20228K">2022-05-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20228K">MOLECULIN BIOTECH, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20228K">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20228K">001-37758</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20228K">47-4671997</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20228K">5300 Memorial Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="d20228K">Suite 950</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="d20228K">Houston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20228K">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20228K">77007</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20228K">713</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20228K">300-5160</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20228K">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20228K">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20228K">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20228K">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="d20228K">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle contextRef="d20228K">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20228K">MBRX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20228K">NASDAQ</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( &A$K%0'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " !H1*Q40%^ ]^X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M:L,P#(=?9?B>*'9H#R;-I:.G#@8K;.QF;+4UB_]@:R1]^R59FS*V!]C1TL^?
M/H$:':4."9]3B)C(8GX87.>SU''#SD11 F1]1J=R.2;\V#R&Y!2-SW2"J/2'
M.B&(JEJ#0U)&D8()6,2%R-K&:*D3*@KIBC=ZP<?/U,TPHP$[=.@I R\YL'::
M&"]#U\ =,,$(D\O?!30+<:[^B9T[P*[)(=LEU?=]V==S;MR!P]O3_F5>M[ ^
MD_(:QU_92KI$W+#;Y-=Z^WC8L5940A35JN#BP(6L5Y*OWR?7'WYW81>,/=I_
M;'P3;!OX=1?M%U!+ P04    " !H1*Q4F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M &A$K%2>D1N&100  .T0   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MI9A=;^(X%(:O9W^%Q=6N5)H//E)&%(FO;M&4EBW,SFI7>V$2 U83F[&=H?S[
M/0Z0,)IPPFAO2)SXO'YL'[]VZ.ZD>M,;Q@QY3V*A[VL;8[8?'4>'&Y90?2NW
M3,";E50)-5!4:T=O%:-1%I3$CN^Z;2>A7-1ZW>S93/6Z,C4Q%VRFB$Z3A*K]
M@,5R=U_S:J<'KWR],?:!T^MNZ9K-F?F\G2DH.;E*Q!,F-)>"*+:ZK_6]CP._
M90.R&G]RMM-G]\1V92GEFRU,HON::XE8S$)C)2A<OK$ABV.K!!Q?CZ*UO$T;
M>'Y_4G_(.@^=65+-AC+^PB.SN:_=U4C$5C2-S:O</;)CAS+ 4,8Z^R6[0]UF
MJT;"5!N9'(.!(.'B<*7OQX$X"_";%P+\8X"?<1\:RBA'U-!>5\D=4;8VJ-F;
MK*M9-,!Q86=E;A2\Y1!G>B,9IC#(AO1%1,;"<+,G$W&8;1BUKF.@$5O5"8^"
M@X.@?T%P2O?$\V^([_K^]]$.H.5\?L[G9W*-*KXS*/+/$]0B$\,2_2_21B-O
MHY&UT;S0QJ';-^25K;DVBD)KSS1A97W'A:8O3^/AYZ?),QE,7A;CX>,-F3P/
M;Q'$9H[81)5/PW!#%OMM*1D>?U?_A%"T<HK6E10SIKBT"1,12+M2(%SJF":_
M?/A0D2CMG*U]U21.1"C55JHL4V[(W  >D8H,92J,VL,U*L7%U4=C!#'($8.K
M$!]XS,ASFBR9*B/!15S7JS>"H'6' -WE0'=7 2WH.YE$,+%\Q</#$KN,ATLV
M@WJS'7B=3H#P=7*^SE5\_2A23.O\AF3K_T643B0NV6JX+IFR1"I.8S)2L"4@
MH)Y;V*C[/U 7.UGJI+CF/.60NYV6BQ&>&;WW<X1#Z_6P,A9R5^[SN-ZCM+N3
MP-@*D_?\GV/+E^U,R6]<A*4S72&Z^ MC*S8'[[K=(6>;26T@=_[FVXMF4B$9
M!*Z+K0^OV!8\W->S.>S#<>PR"BX0> T,I-@9/-S/GV0(8S+;2(%96X4(K,UZ
MRVNC^5[L!QYNV5\4-X8)&)@D2<71UW0I%2ZTHK%&3:+P?P_W[KF,><@-%VLR
MA?RV%E3*@ZM4\A3V[^%F/5.L'L+P,%A@V2%KP43$%'E9K2[,'ZY72588OX?;
M] ]D$ZU3(*L$Q&6K /W"[_WK_'Z<,+6V$_H[2)B-S;8M%?LRM@K%2K;"Z7W<
MF1?<P %#KN" ]>OR-S)G80IKH9P)5[)K!PX#<R/#-PSM[#1?X<F*1G:TYOMD
M*4N3OT)@.GC%;-TO;-W'/?@T*F3\'FZH6+.+9_X*H>?^?-3_ V,JW-S'S;@/
MJ1YEZ?X0TW4I"RY0F4.%G_NX%9_R>P@T"IQ] NONG7QBY5F$:[EP9FVW.FVO
M=,]SSCY>[1\!4VH7E"8Q6X&:>QN N#I\6Q\*1FZS[]FE-/!UG-UN& 5;L!7@
M_4I*<RK83^3\'X[>?U!+ P04    " !H1*Q4GZ ;\+$"  #B#   #0   'AL
M+W-T>6QE<RYX;6S=5VUKVS 0_BM"/V!N8FKBD1BV0&&PC4+S85^56'8$>O%D
MN7/ZZZ>S;"=I=67=A['-H<G=/;J[1W<GF:Y;=Y+\X<BY([V2NMW0HW/-^R1I
M#T>N6/O.-%Q[I#)6,>=56R=M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZFTVY#
M;VA2K"NCSY:4!H-?RA0GCTQNZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,78&F?
M KP(&K <XRBAC05C$C*$[_VX_!DP::U7A90SP24-AF+=,.>XU7=>&18/QA<0
M&>7=J?$,:\M.B^4M/3L,/S[)WMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B<45XH
M!:N-9@.'R6,4?-@#E_(!6OBMNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^,%F)?
MA+W]K;"D$8_&?>S\;O2@?^^,X_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL>]O[+
M"8LUF_S(T5CQY+/!I!R\@5M*'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M<\TU
MMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9 ]IV03NA1.XJRY/K%
M.?7A'=O["_PJOE]?\HIUTNUF<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD<VWL,\E
M=,E[7FY'U=;[021>\%G'!QR>(W?#$T<PGX#%$<"P/!@#S"=X87G^I_VLT/T$
M#..VBB(KU&>%^@2O&+(=/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$#
M#RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q
M_G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"
MIQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04    " !H1*Q4EXJ[',
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MA1H#V#<YD 27Y*IU5%WI>:;7-Y-;2>C@W(-@[^&5C!W-CQ]W]P-02P,$%
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MO-9.&G_FB^$_7G\!4$L! A0#%     @ :$2L5 =!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !H1*Q4
M0%^ ]^X    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    " !H1*Q4F5R<(Q &  "<)P  $P              @ ',
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( &A$K%2>D1N&100
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M2P$"% ,4    " !H1*Q4)!Z;HJT   #X 0  &@              @ &Z$0
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !H1*Q499!Y
MDAD!  #/ P  $P              @ &?$@  6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     "0 ) #X"  #I$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="mbrx20220510_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mbrx.com/20220512/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="mbrx20220510_8k.htm">mbrx20220510_8k.htm</File>
    <File>ex_373512.htm</File>
    <File>mbrx-20220512.xsd</File>
    <File>mbrx-20220512_def.xml</File>
    <File>mbrx-20220512_lab.xml</File>
    <File>mbrx-20220512_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>pic2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mbrx20220510_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "mbrx-20220512_def.xml"
     ]
    },
    "inline": {
     "local": [
      "mbrx20220510_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mbrx-20220512_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mbrx-20220512_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "mbrx-20220512.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 27,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "mbrx",
   "nsuri": "http://www.mbrx.com/20220512",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "mbrx20220510_8k.htm",
      "contextRef": "d20228K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "role": "http://www.mbrx.com/20220512/role/statement-document-and-entity-information",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "mbrx20220510_8k.htm",
      "contextRef": "d20228K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document, Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document, Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity, Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity, Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity, Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity, Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity, Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity, Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity, Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity, File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity, Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity, Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity, Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.mbrx.com/20220512/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001437749-22-012004-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-22-012004-xbrl.zip
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M,&H[=38ZS)$1F6T 1MD#32 K7M+>,/S4T]5@E-ET<7A^T3A2_VH84%$R-3H
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M4UVN5MT74#Y8R6+E"SRZ)_759ZO7O$"2,XB0"#/W3/_NAFN 5;@=):AA'YX
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M]0Z5F1R6I*4E.V-F.EB2EQKLQ)WLPOAGDF#%/SX>2]2/^O<WWOD'4$L#!!0
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M+J_13TEUC+BN$W-6<=>R2_&SR[8$P^Z&SG'+DO225"$E"ZVFA0@3$BNDL%A
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MX0GB!/2#.$A21$N"L:A]ZR4[QF=\W+^M#(VZIZV8DJFD3!2DAHM%$6+79?F
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MQ\(*>J4A?/K@U'Y_>72G;53C?FY*,=8*4A;$Z2!<<=['8Y*K,;4KU8L^6_7
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MY7671:\RLY*W5!3P10U.:GX'1H^101GL&NS#T=QFHV0]8MJ4AM'YTLENXMW
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M>"TR,#(R,#4Q,E]L86(N>&UL4$L! A0#%     @ :$2L5#_/09F(!   H2\
M !4              ( !="\  &UB<G@M,C R,C U,3)?<')E+GAM;%!+ 0(4
M Q0    ( &A$K%1ICP*'FPX  )9@   3              "  2\T  !M8G)X
M,C R,C U,3!?.&LN:'1M4$L! A0#%     @ :$2L5.@^AAE"'P  NB    @
M             ( !^T(  '!I8S(N:G!G4$L%!@     '  < N@$  &-B
!  $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
